Chronic Hepatic Encephalopathy Treated with Oral Lactose in a Patient with Lactose Malabsorption
- 1 August 1974
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 291 (5) , 240-241
- https://doi.org/10.1056/nejm197408012910508
Abstract
LACTULOSE has been used successfully in the treatment of hepatic encephalopathy.1 It appears that oral lactulose, by producing a disaccharide malabsorption, makes the intraluminal gut pH more acid, decreasing the absorption of ammonia from the gut.2 Since lactulose is not available in this country for routine clinical use,3 we suggested the use of oral lactose in the treatment of hepatic encephalopathy if the patient has lactose malabsorption.4 If such treatment is successful, it will have worldwide application since 70 to 75 per cent of American blacks, 80 per cent of American Indians, 95 to 100 per cent of Orientals, 50 . . .Keywords
This publication has 6 references indexed in Scilit:
- Treatment of chronic portal-systemic encephalopathy with lactulose: Report of six patients and review of the literatureThe American Journal of Medicine, 1971
- Ammonia Absorption from the Human ColonGastroenterology, 1971
- Disaccharidase DeficiencyThe American Journal of Clinical Nutrition, 1969
- HEPATIC COMA DUE TO ACUTE HEPATIC NECROSIS TREATED BY EXCHANGE BLOOD-TRANSFUSIONThe Lancet, 1967
- MILK-AND-CHEESE DIET IN PORTAL-SYSTEMIC ENCEPHALOPATHYThe Lancet, 1966
- A WARD TEST FOR SUGAR IN FÆCESThe Lancet, 1964